Compounds > trimethoprim
Page last updated: 2024-08-16

trimethoprim and fleroxacin

trimethoprim has been researched along with fleroxacin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Hohl, P; Kafader, FM; Salfinger, M1
Andrews, JM; Ashby, JP; Matthews, RS; Wise, R1
Cullmann, W; Dechène, M; Stieglitz, M1
Dubois, J; Fontaine, V1
M'imunya, JM; Mutua, FM; Wiysonge, CS1

Reviews

1 review(s) available for trimethoprim and fleroxacin

ArticleYear
Genital ulcer disease treatment for reducing sexual acquisition of HIV.
    The Cochrane database of systematic reviews, 2012, Aug-15, Issue:8

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chancroid; Female; Fleroxacin; HIV Infections; HIV Seronegativity; Humans; Male; Penicillin G Benzathine; Randomized Controlled Trials as Topic; Sulfamethoxazole; Syphilis; Trimethoprim

2012

Other Studies

9 other study(ies) available for trimethoprim and fleroxacin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1987
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Blood Proteins; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Ofloxacin; Oxazines; Protein Binding; Pseudomonas aeruginosa; Quinolines; Quinolones; Staphylococcus; Streptococcus; Trimethoprim

1988
[Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
    Immunitat und Infektion, 1988, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Humans; Mutation; Ofloxacin; Serratia marcescens; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1988
In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D

    Topics: Ampicillin; Anti-Infective Agents; Bacteria; Ciprofloxacin; Female; Fleroxacin; Genital Diseases, Female; Genital Diseases, Male; Male; Nalidixic Acid; Penicillins; Tetracyclines; Trimethoprim; Urinary Tract Infections

1988